Abstract
Background: Leprosy leads to nerve damage and slow-healing ulcers, which are treatable with routine therapy. There has been a recent resurgence of interest in the use of honey for the treatment of different kinds of wounds.
Objective: The aim of this study, Honey Experiment on Leprosy Ulcer (HELP), is to evaluate the healing properties of raw, unadulterated African honey in comparison with normal saline dressing for the treatment leprosy ulcers.
Methods: This is a multicenter, comparative, prospective, single-blinded, parallel-group, and 1:1 individually randomized controlled trial to be conducted at The Leprosy Referral Hospital, Chanchaga in Minna, Niger State, North Central Nigeria, and St. Benedict Tuberculosis and Leprosy Rehabilitation Hospital in Ogoja, Cross River State, South-South Nigeria. Raw, unadulterated honey will be used in the ulcer dressing of eligible, consenting participants in the intervention group, whereas those in the control group will be treated by dressing with normal saline. The main outcomes will be the proportion of complete healing and the rate of healing up to 84 days after randomization. Follow-up will be conducted 6 months after randomization. We aim to enroll 90‐130 participants into the study. Blinded observers will examine photographs of ulcers to determine the outcomes.
Results: The recruitment of trial participants began on March 14, 2022, and has been continuing for approximately 24 months.
Conclusions: Our study will provide an unbiased estimate of the effect of honey on the healing of neuropathic ulcers.
Trial Registration: ISRCTN registry ISRCTN10093277; https://www.isrctn.com/ISRCTN10093277
Objective: The aim of this study, Honey Experiment on Leprosy Ulcer (HELP), is to evaluate the healing properties of raw, unadulterated African honey in comparison with normal saline dressing for the treatment leprosy ulcers.
Methods: This is a multicenter, comparative, prospective, single-blinded, parallel-group, and 1:1 individually randomized controlled trial to be conducted at The Leprosy Referral Hospital, Chanchaga in Minna, Niger State, North Central Nigeria, and St. Benedict Tuberculosis and Leprosy Rehabilitation Hospital in Ogoja, Cross River State, South-South Nigeria. Raw, unadulterated honey will be used in the ulcer dressing of eligible, consenting participants in the intervention group, whereas those in the control group will be treated by dressing with normal saline. The main outcomes will be the proportion of complete healing and the rate of healing up to 84 days after randomization. Follow-up will be conducted 6 months after randomization. We aim to enroll 90‐130 participants into the study. Blinded observers will examine photographs of ulcers to determine the outcomes.
Results: The recruitment of trial participants began on March 14, 2022, and has been continuing for approximately 24 months.
Conclusions: Our study will provide an unbiased estimate of the effect of honey on the healing of neuropathic ulcers.
Trial Registration: ISRCTN registry ISRCTN10093277; https://www.isrctn.com/ISRCTN10093277
Original language | English |
---|---|
Article number | e50970 |
Number of pages | 11 |
Journal | JMIRx Med |
Volume | 5 |
DOIs | |
Publication status | Published - 1 Mar 2024 |
Bibliographical note
Acknowledgments:We acknowledge the contribution of the Public Health Department of the Niger State Ministry of Health and The Leprosy Referral Hospital, Chanchaga to the clinical trial. We also acknowledge members of the communities affected with leprosy in Nigeria for their assurance of cooperation during pretrial engagements. We thank the chair and members of the Trial Steering Committee—Dr Doyin Odubanjo, Professor Kara Hanson, Dr Paul Saunderson, and Dr Jerry Joshua—for their constructive advice on the trial. We also acknowledge the support of Dr Indra Napit, Dilip Shrestha, Karuna Neupane, and Anjali Shrivastav from The Leprosy Mission Nepal for their support in training for the trial. This research was funded by the National Institute for Health Research (NIHR: 200132) using UK aid from the UK government to support global health research. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the UK Department of Health and Social Care. The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.
Keywords
- leprosy
- Ulcers
- wounds
- neuropathy
- nerves
- Africa
- randomised controlled trial
- RCT